Aromatase inhibitors

TEVA B1 Pill - yellow round, 6mm

Pill with imprint TEVA B1 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Letrozole is used in the treatment of Breast Cancer, Metastatic; Breast Cancer, Adjuvant; Breast Cancer and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Letrozole (Letrozole [ let-roe-zol ])-TEVA B1-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-TEVA B1-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-TEVA B1-2.5 mg-Yellow-Round
Letrozole (Letrozole [ let-roe-zol ])-TEVA B1-2.5 mg-Yellow-Round

Letrozole
Generic Name: letrozole [ let-roe-zol ]
Imprint: TEVA B1
Strength: 2.5 mg
Color: Yellow
Size: 6.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Aromatase inhibitors Hormones / antineoplastics
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Silicon dioxide, FD&C Blue No. 2, Indigotindisulfonate sodium, FD&C Yellow No. 5, Ferric oxide yellow, Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Polyethylene glycol 3350, Polyethylene glycol 4000, Sodium starch glycolate type A potato, Corn starch, Magnesium silicate, Titanium dioxide,
Latest News
Related Drugs